Flow Cytometry Market 2018 | Scope of Current and Future Industry 2026
Flow
cytometry is a laser- or impedance-based, biophysical
technology employed in cell counting, cell sorting, biomarker
detection and protein engineering. The process is conducted by
suspending cells in a stream of fluid and passing them through an
electronic detection apparatus. The simultaneous multiparametric
analysis of the physical and chemical characteristics of particles is
facilitated by a flow cytometer at a speed of up to thousands of
particles per second. The process is used in the diagnosis of health
disorders such as blood cancers along with several applications in
basic research, clinical practice, and clinical trials. Flow
cytometry facilitates study of the expression of cell surface and
intracellular molecules along with characterization of different cell
types in a heterogeneous cell population. Moreover, flow cytometry
also allows simultaneous multi-parameter analysis of single cells.
The combination of technological improvements, growing research
activities in life science and increasing clinical application of
flow cytometry in diagnosis of HIV and cancer are some of the major
factors driving growth of the flow cytometry market.
Flow cytometry is
recently undergone new developments with availability of robust
photodetectors and new laser emitters, use of LED lamps as emitter,
and changes in analytical capacity (multidimensional analysis
software). Furthermore, new approaches combining existing
technologies with routine laboratory procedures, such as imaging,
which makes the acquisition of images of cells possible in real time
as they pass by the interrogation point are some of the major
advancements in flow cytometry. The process also finds application in
cytology, hematology, immunology, and microbiology, among other
research fields.
Market Dynamics
Flow cytometry is
quite an unexplored field, which is rapidly advancing due to
technological advancements in the recent past. The increasing FDA
approval for various clinical test favors the growth of flow
cytometry market in near future. For instance, in 2017 the use of
flow cytometer in detection of leukemia & lymphoma cancers was
approved by FDA. Therefore, rising prevalence of HIV and cancer
favors the growth of flow cytometer market.
Whereas, number of
advantages of flow cytometer over traditional analytical methods such
as, ELISA that include the ability of flow cytometer to deliver
precise and accurate results in less time, with same price.
Furthermore, in 2017
there were number of product launches, which supports the growth of
flow cytometry market in near future. For instance, Beckman Coulter
Life Sciences received FDA approval for product named the Navios EX
flow cytometer in August 2017.
Inquire Here
Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1152
Increase in
clinical applications of flow cytometry is expected to favor the flow
cytometry market
The use of flow
cytometry in clinical laboratory has grown substantially due to the
development of smaller, user-friendly, less expensive instruments and
increasing number of research application such as, immunophenotyping,
cell sorting, cell cycle analysis, Apoptosis, cell proliferation
assays, and intracellular calcium flux is expected to favor the
growth of flow cytometry market. Besides, flow cytometry has a unique
ability to investigate large cell populations at the single-cell
level. This favors the adoption of flow cytometry for clinical
application.
Furthermore, flow
cytometry is also gaining attraction in drug discovery and
development, which helps transforming every stage of preclinical and
clinical development, that guide new product evaluation, selection
and monitoring. Flow cytometry increases the probability of success
in drug development and also allows for more informed decision
making. The demand for flow cytometry is growing at all phases of
development from early to late favoring the growth of flow cytometry
use in industry for drug development process.
Some major players
operating in the flow cytometry market are Becton Dickinson and
Company, General Electric Company, Luminex Corporation, Thermo Fisher
Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH,
Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc.
and Danaher Corporation.
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment